Rodriguez-Peralvarez, ManuelSalcedo, MagdalenaColmenero, JordiPons, Jose Antonio2023-02-092023-02-092020-08-11Rodriguez-Peralvarez M, Salcedo M, Colmenero J, Pons JA. Modulating immunosuppression in liver transplant patients with COVID-19. Gut. 2021 Jul;70(7):1412-1414http://hdl.handle.net/10668/16119We read with great interest the COVID-LT study by C Becchetti et al.Which included 57 liver transplant (LT) patients from 12 European institutions who were diagnosed with coronavirus disease 2019 (COVID-19). Simultaneously, the Spanish Society of Liver Transplantation (SETH) has conducted a nationwide prospective study including 22 transplant institutions and 111 LT patients with COVID-19. Since there were only nine overlapped cases, both cohorts add up to 159 LT patients and taken together their close analysis (table 1) may derive in practical conclusions.enImmunoregulationLiver transplantationCOVID-19Graft rejectionHumansImmunosuppression therapyLiver transplantationSARS-CoV-2research article32816964open accessHumanosRechazo de injertoTerapia de inmunosupresiónTrasplante de hígado10.1136/gutjnl-2020-3226201468-3288https://gut.bmj.com/content/gutjnl/70/7/1412.full.pdf